Concepedia

J. Cornelis de Vos

JC

4

Publications

433

Citations

4

H-Index

1991

Active since

Affiliations

Erasmus University Rotterdam(Current)

J. Cornelis de Vos is an author at Erasmus University Rotterdam specializing in vascular biology, clinical trials, and atherosclerosis.

Top concepts

MedicineCardiologyThrombosisPharmacologyAtherosclerosisClinical TrialsPharmacotherapyVascular BiologyCardiovascular DiseaseCoronary Heart Disease

Publications per year

1991–2003

4

Publications

4

Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).

Patrick W. Serruys, Wolfgang Rutsch, Guy R. Heyndrickx et al. · Circulation · 1991 · 238 citations · Full text

Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.

Benno J. Rensing, Walter Hermans, J. Cornelis de Vos et al. · Circulation · 1993 · 149 citations · Full text

Anti-restenosis Trials.

de Feyter Pj, J. Cornelis de Vos, BJ Rensing · PubMed · 2000 · 33 citations

Thrombosis, Translational Medicine, Percutaneous Coronary Intervention +15

Sonotherapy, antirestenotic therapeutic ultrasound in coronary arteries: The first clinical experience

Evelyn Regar, Attila Thury, Wim J. van der Giessen et al. · Catheterization and Cardiovascular Interventions · 2003 · 13 citations

Rows per page

1–4 of 4